Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,799
Closed -$280K 1624
2025
Q3
$280K Sell
30,799
-19,896
-39% -$248K ﹤0.01% 1419
2025
Q2
$777K Sell
50,695
-3,320
-6% -$55.9K 0.01% 966
2025
Q1
$1.05M Buy
54,015
+493
+0.9% +$13.7K 0.02% 785
2024
Q4
$1.65M Buy
53,522
+16,099
+43% +$441K 0.02% 598
2024
Q3
$956K Buy
37,423
+11,482
+44% +$345K 0.01% 795
2024
Q2
$759K Buy
+25,941
New +$770K 0.01% 858

Other funds holding DAVA

Oppenheimer & Co's DAVA Position: Q4 2025 in Review

Oppenheimer & Co sold out of Endava (DAVA) in Q4 2025, closing a stake of 30,799 shares — an estimated $280K sold.

Oppenheimer & Co first reported a position in DAVA in Q2 2024 and held it in 6 quarters. The position peaked at $1.65M in Q4 2024. 101 funds tracked by Wall St. Rank hold DAVA as of Q4 2025.

  • Oppenheimer & Co reported no remaining Endava position as of Q4 2025 after selling out during the quarter.
  • Oppenheimer & Co sold 30,799 Endava shares in Q4 2025, an estimated $280K.
  • Oppenheimer & Co first reported a position in Endava in Q2 2024 and held it in 6 quarters.
  • Oppenheimer & Co's Endava position peaked at $1.65M in Q4 2024.
  • 101 funds tracked by Wall St. Rank held Endava as of Q4 2025.

Based on Oppenheimer & Co's 13F filing for Q4 2025, filed 2 Feb 2026.